Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (2009 - 2025)

Vertex Pharmaceuticals' Interest Coverage Ratio history runs 18 years deep, the most recent figure standing at 2.71 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 53.59% year-over-year to 2.71; the TTM figure through Mar 2026 stood at 11.14 (up 636.27% YoY), while the FY2025 annual figure was 9.56, up 1501.17% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 2.71, down from 22.71 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 89.86 in Q4 2023, with the low at 11.36 in Q2 2024.
• The 5-year median for Interest Coverage Ratio is 4.1 (2023), against an average of 15.73.
• The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio soared 1798.73% in 2022, then sank 377.22% in 2024.
• Vertex Pharmaceuticals' Interest Coverage Ratio stood at 75.44 in 2022, then climbed by 19.12% to 89.86 in 2023, then slumped by 53.4% to 41.88 in 2024, then slumped by 45.77% to 22.71 in 2025, then slumped by 88.08% to 2.71 in 2026.
• Business Quant data shows VRTX's Interest Coverage Ratio at 2.71 in Q1 2026, 22.71 in Q4 2025, and 2.81 in Q3 2025.